Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
48.12B
Market cap48.12B
Price-Earnings ratio
35.32
Price-Earnings ratio35.32
Dividend yield
Dividend yield
Average volume
6.81M
Average volume6.81M
High today
$82.97
High today$82.97
Low today
$81.69
Low today$81.69
Open price
$82.65
Open price$82.65
Volume
1.47M
Volume1.47M
52 Week high
$87.09
52 Week high$87.09
52 Week low
$64.89
52 Week low$64.89

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $81.96, with a market capitalization of 48.12B. The stock trades at a price-to-earnings (P/E) ratio of 35.32.

During the trading session on 2025-11-06, Edwards Lifesciences(EW) shares reached a daily high of $82.97 and a low of $81.69. At a current price of $81.96, the stock is +0.3% higher than the low and still -1.2% under the high.

Trading activity shows a volume of 1.47M, compared to an average daily volume of 6.81M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.09 and a low of $64.89.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.09 and a low of $64.89.

EW News

Simply Wall St 8h
How Strong Clinical Data and Upbeat Guidance at Edwards Lifesciences Have Changed Its Investment Story

In the past week, Edwards Lifesciences reported third quarter results with US$1.55 billion in sales, raised its full-year sales growth guidance, announced a tra...

How Strong Clinical Data and Upbeat Guidance at Edwards Lifesciences Have Changed Its Investment Story
TipRanks 3d
Edwards Lifesciences price target raised to $90 from $87 at Truist

Truist raised the firm’s price target on Edwards Lifesciences (EW) to $90 from $87 and keeps a Hold rating on the shares. The company delivered a solid Q3 reven...

TipRanks 6d
Edwards Lifesciences Reports Strong Earnings and Growth

Edwards Lifesciences Corp. ((EW)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of...

Analyst ratings

62%

of 34 ratings
Buy
61.8%
Hold
38.2%
Sell
0%

More EW News

Seeking Alpha 7d
Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3

Earnings Call Insights Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3 Oct. 30, 2025 9:27 PM ET E...

Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3
Nasdaq 7d
Edwards Lifesciences Corp. Q3 Profit Decreases, But Beats Estimates

(RTTNews) - Edwards Lifesciences Corp. (EW) reported earnings for third quarter that Decreased from the same period last year but beat the Street estimates. Th...

Edwards Lifesciences Corp. Q3 Profit Decreases, But Beats Estimates
TipRanks 7d
Edwards Lifesciences Announces CFO Transition Plan

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Investor's Business Daily 7d
Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance

Edwards Lifesciences (EW) stock jumped late Thursday after the medtech company reported adjusted profit of 67 cents per share on $1.55 billion in third-quarter...

Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance
Nasdaq 7d
Edwards Lifesciences Q3 25 Earnings Conference Call At 5:00 PM ET

(RTTNews) - Edwards Lifesciences Corp. (EW) will host a conference call at 5:00 PM ET on October 30, 2025, to discuss Q3 25 earnings results. To access the liv...

Edwards Lifesciences Q3 25 Earnings Conference Call At 5:00 PM ET

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.